|
ViziLite ® Plus oral lesion identification and marking system
The newest tool in the fight against oral disease is the ViziLite ® Plus oral lesion identification and marking system. ViziLite ® Plus, from Zila Pharmaceuticals, combines the oral screening technology of ViziLite, an advanced chemiluminescent light technology to help detect oral abnormalities, with TBlue630T. TBlue630 is the only patented pharmaceutical-grade form of toluidine blue that has been cleared by the FDA for use in marking lesions identified during a ViziLite examination. ViziLite Plus makes oral screening more comprehensive than ever before and is indicated for use in individuals at increased risk of oral cancer. If ViziLite reveals an abnormality, TBlue630 can be used to mark suspicious lesions for further evaluation. |
 Chess & Taub Family DentistryAppointments:
|
© 2012, Internet Dental Alliance, Inc. All Rights Reserved - Privacy Policy - Terms of Use
Chess & Taub Family Dentistry, 201 Old York Road Suite 200, Jenkintown, Pennsylvania 19046 - (215) 576-0421
Dr. Harry Taub and Dr. Gregory Chess
